Largest biotech companies by market cap: 55 companies with a combined market value of $1.057 T. Amgen Inc. (AMGN) leads at $249.37 B. Biological product and biotechnology research companies ranked by market value. Rankings update as fresh market data lands; click any company for its financial statements, charts, and SEC filing history.
| Rank | Company | Industry | Market Cap |
|---|---|---|---|
| 1 | Biological Products, (No Diagnostic Substances) | $249.37 B | |
| 2 | Biological Products, (No Diagnostic Substances) | $207.63 B | |
| 3 | Biological Products, (No Diagnostic Substances) | $105.32 B | |
| 4 | Aargenx SEARGX | Biological Products, (No Diagnostic Substances) | $56.15 B |
| 5 | Services-Commercial Physical & Biological Research | $44.43 B | |
| 6 | RRevolution Medicines, Inc.RVMD | Biological Products, (No Diagnostic Substances) | $40.68 B |
| 7 | Biological Products, (No Diagnostic Substances) | $36.75 B | |
| 8 | Services-Commercial Physical & Biological Research | $24.08 B | |
| 9 | Biological Products, (No Diagnostic Substances) | $22.01 B | |
| 10 | Services-Commercial Physical & Biological Research | $18.67 B | |
| 11 | Biological Products, (No Diagnostic Substances) | $16.93 B | |
| 12 | Biological Products, (No Diagnostic Substances) | $16.59 B | |
| 13 | Services-Commercial Physical & Biological Research | $16.24 B | |
| 14 | IICON Public Limited CompanyICLR | Services-Commercial Physical & Biological Research | $15.63 B |
| 15 | Biological Products, (No Diagnostic Substances) | $12.38 B | |
| 16 | Biological Products, (No Diagnostic Substances) | $11.41 B | |
| 17 | Biological Products, (No Diagnostic Substances) | $11.03 B | |
| 18 | Biological Products, (No Diagnostic Substances) | $10.54 B | |
| 19 | AApogee Therapeutics, Inc.APGE | Biological Products, (No Diagnostic Substances) | $10.11 B |
| 20 | Biological Products, (No Diagnostic Substances) | $9.50 B | |
| 21 | PVaxcyte, Inc.PCVX | Biological Products, (No Diagnostic Substances) | $8.94 B |
| 22 | Biological Products, (No Diagnostic Substances) | $8.85 B | |
| 23 | IImmunityBio, Inc.IBRX | Biological Products, (No Diagnostic Substances) | $8.39 B |
| 24 | Biological Products, (No Diagnostic Substances) | $7.51 B | |
| 25 | AArcellxACLX | Biological Products, (No Diagnostic Substances) | $6.73 B |
| 26 | IImmunovant, Inc.IMVT | Biological Products, (No Diagnostic Substances) | $5.83 B |
| 27 | CCG Oncology, Inc.CGON | Biological Products, (No Diagnostic Substances) | $5.74 B |
| 28 | SScholar Rock Holding CorporationSRRK | Biological Products, (No Diagnostic Substances) | $5.45 B |
| 29 | Biological Products, (No Diagnostic Substances) | $4.71 B | |
| 30 | Biological Products, (No Diagnostic Substances) | $4.34 B | |
| 31 | IInhibrx Biosciences, Inc.INBX | Biological Products, (No Diagnostic Substances) | $4.21 B |
| 32 | Biological Products, (No Diagnostic Substances) | $3.46 B | |
| 33 | Biological Products, (No Diagnostic Substances) | $3.26 B | |
| 34 | Biological Products, (No Diagnostic Substances) | $3.20 B | |
| 35 | DDenali Therapeutics Inc.DNLI | Biological Products, (No Diagnostic Substances) | $3.16 B |
| 36 | Biological Products, (No Diagnostic Substances) | $3.08 B | |
| 37 | AADMA Biologics, Inc.ADMA | Biological Products, (No Diagnostic Substances) | $2.93 B |
| 38 | TTarsus Pharmaceuticals, Inc.TARS | Biological Products, (No Diagnostic Substances) | $2.90 B |
| 39 | Biological Products, (No Diagnostic Substances) | $2.68 B | |
| 40 | Biological Products, (No Diagnostic Substances) | $2.64 B | |
| 41 | CHemab Therapeutics Holdings, Inc.COAG | Biological Products, (No Diagnostic Substances) | $2.15 B |
| 42 | KKodiak Sciences Inc.KOD | Biological Products, (No Diagnostic Substances) | $2.02 B |
| 43 | Biological Products, (No Diagnostic Substances) | $1.99 B | |
| 44 | Biological Products, (No Diagnostic Substances) | $1.98 B | |
| 45 | VVir Biotechnology, Inc.VIR | Biological Products, (No Diagnostic Substances) | $1.93 B |
| 46 | Biological Products, (No Diagnostic Substances) | $1.88 B | |
| 47 | MMaze Therapeutics, Inc.MAZE | Biological Products, (No Diagnostic Substances) | $1.80 B |
| 48 | AAbsci CorporationABSI | Services-Commercial Physical & Biological Research | $1.71 B |
| 49 | Biological Products, (No Diagnostic Substances) | $1.69 B | |
| 50 | IImmunocore Holdings plcIMCR | Biological Products, (No Diagnostic Substances) | $1.53 B |
| 51 | AAlvotechALVO | Biological Products, (No Diagnostic Substances) | $1.46 B |
| 52 | TTaysha Gene Therapies, Inc.TSHA | Biological Products, (No Diagnostic Substances) | $1.23 B |
| 53 | Biological Products, (No Diagnostic Substances) | $844.79 M | |
| 54 | Biological Products, (No Diagnostic Substances) | $831.24 M | |
| 55 | Biological Products, (No Diagnostic Substances) | $713.69 M |
Industry membership comes from each company's SEC-registered SIC classification, parsed from EDGAR submissions. Market capitalizations refresh continuously from cached market data combined with SEC-reported share counts. See the full market cap rankings or the IPO filings tracker.